HepaCAM inhibits clear cell renal carcinoma 786-0 cell proliferation via blocking PKCε translocation from cytoplasm to plasma membrane (Q39025188)

8 September 2017

title

HepaCAM inhibits clear cell renal carcinoma 786-0 cell proliferation via blocking PKCε translocation from cytoplasm to plasma membrane (English)

1 reference

8 September 2017

1 reference

Bing Tan

1

1 reference

8 September 2017

Jinxiang Tan

2

1 reference

8 September 2017

Hongfei Du

3

1 reference

8 September 2017

Zhen Quan

4

1 reference

8 September 2017

Xiangdong Xu

5

1 reference

8 September 2017

Xiaoliang Jiang

6

1 reference

8 September 2017

Chunli Luo

7

1 reference

8 September 2017

Xiaohou Wu

8

1 reference

8 September 2017

publication date

11 February 2014

1 reference

Molecular and Cellular Biochemistry

8 September 2017

published in

1 reference

8 September 2017

volume

391

1 reference

8 September 2017

issue

1-2

1 reference

8 September 2017

page(s)

95-102

1 reference

EAU guidelines on renal cell carcinoma: the 2010 update

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

Cloning and characterization of hepaCAM, a novel Ig-like cell adhesion molecule suppressed in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

Expression and clinical significance of hepaCAM and VEGF in urothelial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

Expression of hepaCAM and its effect on proliferation of tumor cells in renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

hepaCAM and p-mTOR closely correlate in bladder transitional cell carcinoma and hepaCAM expression inhibits proliferation via an AMPK/mTOR dependent pathway in human bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

Exploration of the correlations between interferon-γ in patient serum and HEPACAM in bladder transitional cell carcinoma, and the interferon-γ mechanism inhibiting BIU-87 proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

The immunoglobulin-like cell adhesion molecule hepaCAM induces differentiation of human glioblastoma U373-MG cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

Functional significance of the hepaCAM gene in bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

HepaCAM induces G1 phase arrest and promotes c-Myc degradation in human renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

Genetic ablation of PKC epsilon inhibits prostate cancer development and metastasis in transgenic mouse model of prostate adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

Protein kinase Cε as a cancer marker and target for anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

Protein kinase C epsilon is overexpressed in primary human non-small cell lung cancers and functionally required for proliferation of non-small cell lung cancer cells in a p21/Cip1-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

Importance of C1B domain for lipid messenger-induced targeting of protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

The Coatomer Protein '-COP, a Selective Binding Protein (RACK) for Protein Kinase C

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

Rational design of a selective antagonist of epsilon protein kinase C derived from the selective allosteric agonist, pseudo-RACK peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

A 20-amino acid module of protein kinase C{epsilon} involved in translocation and selective targeting at cell-cell contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

Predictive value of sphingosine kinase 1 expression in neoadjuvant treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

Structural and functional analyses of a novel ig-like cell adhesion molecule, hepaCAM, in the human breast carcinoma MCF7 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

epsilonPKC confers acute tolerance to cerebral ischemic reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

Reduction of beta-amyloid levels by novel protein kinase C(epsilon) activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

Central role of protein kinase Cepsilon in constitutive activation of ERK1/2 and Rac1 in the malignant cells of hairy cell leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

Protein kinase Cepsilon makes the life and death decision

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

Activation of nuclear factor κB (NF-κB) in prostate cancer is mediated by protein kinase C epsilon (PKCepsilon)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-014-1991-9

Changes in protein kinase C epsilon phosphorylation status and intracellular localization as 3T3 and 3T6 fibroblasts grow to confluency and quiescence: a role for phosphorylation at ser-729?

21 January 2018

1 reference

12 December 2020

The coatomer protein beta'-COP, a selective binding protein (RACK) for protein kinase Cepsilon

1 reference

12 December 2020

Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC)

1 reference

12 December 2020

Protein kinase C-epsilon (PKC-epsilon): its unique structure and function

1 reference

12 December 2020

Regulation of beta1 integrin expression by PKCepsilon in renal cancer cells

1 reference

12 December 2020

10.1007/S11010-014-1991-9

Identifiers

DOI

1 reference

8 September 2017

1 reference